What is the recommended tapering regimen when switching a patient from Ativan (lorazepam) to Valium (diazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam to Diazepam Tapering Regimen

When switching a patient from Ativan (lorazepam) to Valium (diazepam), use a gradual tapering schedule with an initial conversion ratio of 1 mg lorazepam to 10 mg diazepam, followed by a 5-10% dose reduction every 1-2 weeks based on withdrawal symptoms.

Conversion Principles

The conversion from lorazepam to diazepam requires careful consideration of their pharmacological differences:

  • Potency difference: Lorazepam is approximately 10 times more potent than diazepam (1 mg lorazepam ≈ 10 mg diazepam) 1
  • Pharmacokinetic differences:
    • Diazepam has a longer half-life (20-100 hours) and active metabolites
    • Lorazepam has an intermediate half-life (10-20 hours) with no active metabolites

Step-by-Step Tapering Protocol

1. Initial Assessment

  • Evaluate current lorazepam dose, duration of use, and patient risk factors
  • Screen for concurrent substance use, particularly opioids 1
  • Assess for underlying psychiatric conditions requiring treatment

2. Conversion Process

  • Day 1-3: Replace 50% of lorazepam dose with equivalent diazepam
  • Day 4-7: Replace remaining 50% of lorazepam with equivalent diazepam
  • Example: For a patient on 6 mg/day lorazepam
    • Days 1-3: 3 mg lorazepam + 30 mg diazepam daily
    • Days 4-7: 60 mg diazepam daily

3. Diazepam Tapering Schedule

  • Standard taper: Reduce by 5-10% of the original dose every 1-2 weeks 1
  • For high doses (>60 mg/day): Initial reductions can be larger (10-15%)
  • For lower doses (<30 mg/day): Slower reductions (5% every 2 weeks)

4. Monitoring and Adjustment

  • Assess for withdrawal symptoms before each dose reduction
  • Common withdrawal symptoms include:
    • Anxiety, irritability, insomnia
    • Tremor, diaphoresis, agitation
    • Hypertension, tachycardia
    • Hyperalgesia, myoclonus 2

5. Special Considerations

Elderly Patients

  • Use more gradual tapering (5% reduction every 2-4 weeks) 2, 1
  • Start with lower initial diazepam equivalent dose (25-50% reduction)

Patients with Liver Disease

  • Consider using a more gradual taper (2.5-5% reduction)
  • Monitor for signs of over-sedation due to impaired metabolism 1

Patients with History of Seizures

  • More gradual tapering is essential (2.5-5% every 2-4 weeks)
  • Consider adjunctive anticonvulsant therapy during taper 1

Adjunctive Treatments for Withdrawal Symptoms

For specific withdrawal symptoms, consider the following medications 1:

  • Sympathetic hyperactivity: Clonidine
  • Insomnia: Trazodone, mirtazapine, or gabapentin
  • Anxiety: Hydroxyzine
  • Pain: Scheduled acetaminophen (not exceeding 3000mg daily)

Pitfalls to Avoid

  1. Too rapid tapering: Can precipitate severe withdrawal symptoms including seizures
  2. Incomplete conversion: Ensure full transition to diazepam before beginning taper
  3. Ignoring breakthrough symptoms: Adjust taper rate based on patient response
  4. Overlooking concurrent substance use: Particularly opioids or alcohol which may complicate withdrawal

Benefits of Using Diazepam for Tapering

Diazepam is preferred for tapering due to:

  • Longer half-life providing smoother withdrawal
  • Self-tapering effect from active metabolites
  • Lower incidence of breakthrough symptoms and rebound phenomena
  • Decreased seizure risk during withdrawal 3

The gradual, symptom-based approach to tapering is safe and effective even in patients with liver disease or elderly patients when properly monitored 3.

References

Guideline

Management of Benzodiazepine Use in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.